Finding a suitable donor is one of the most important steps in preparing for a bone marrow transplant. This procedure can help treat certain blood cancers, inherited blood disorders and conditions that affect the bone marrow’s ability to produce healthy blood cells. However, successful transplantation depends on several factors, including the patient’s diagnosis, overall health and compatibility with the donor.
Understanding how matching works can help patients and families prepare for treatment and make informed decisions. In this guide, we’ll explain the matching process, the role of HLA testing, the types of donors available and what happens after a suitable match is identified.
What Is Bone Marrow Transplantation?
Bone marrow is the soft tissue inside certain bones that produces blood-forming stem cells. These cells develop into red blood cells, white blood cells and platelets, which carry oxygen, fight infections and help control bleeding.
A stem cell transplant may use blood-forming stem cells collected from the bone marrow, bloodstream or umbilical cord blood, depending on the patient’s condition and treatment plan.
It may be recommended for conditions such as:
- Leukaemia and certain other blood cancers
- Severe aplastic anaemia and other bone marrow failure disorders
- Thalassaemia major
- Sickle cell disease
- Certain inherited immune or metabolic disorders
The treatment approach depends on the condition and the patient’s individual circumstances. Some patients receive their own previously collected stem cells, while others require cells from a donor.
What Is Donor Matching?
Donor matching is the process of comparing a patient’s tissue markers with those of a potential donor to determine whether their stem cells are compatible.
For an allogeneic transplant, the patient receives stem cells from another person. The donor may be a sibling, parent, another relative or an unrelated individual.
Compatibility matters because the immune system recognises cells through specific markers. If the donor and recipient are insufficiently compatible, the risk of certain complications may increase, including graft-versus-host disease (GVHD), in which donor immune cells attack the recipient’s tissues.
Doctors therefore assess compatibility alongside other factors, such as donor health, age, availability and the patient’s medical needs.
What Is HLA Matching?
HLA matching is the main method used to assess compatibility between a patient and a potential donor.
Human leukocyte antigens (HLAs) are proteins, or markers, found on most cells in the body. The immune system uses them to distinguish the body’s own cells from foreign cells.
HLA markers are inherited from biological parents, with approximately half of a person’s HLA inheritance coming from each parent. This explains why close family members may be suitable donors.
A closer HLA match can help improve the chances of successful engraftment, when transplanted stem cells begin producing new blood cells, and reduce the risk of certain transplant complications. However, the best donor is not determined by HLA compatibility alone.
How Does the Donor Matching Process Work?
The process of bone marrow donor usually involves several stages, from identifying potential donors to confirming compatibility and ensuring that donation is safe.
1. HLA Typing
The first step is identifying the patient’s HLA profile. Doctors arrange an HLA typing test using a blood sample or a swab from inside the cheek. A laboratory analyses the sample to identify the patient’s tissue markers.
Potential donors undergo similar testing so that their results can be compared with the patient’s profile.
2. Testing Family Members
Doctors often begin by testing the patient’s biological siblings, particularly those who share both parents. Each such sibling has approximately a 25% chance of being a full HLA match.
Parents and children may also be considered for a half-matched transplant. However, being related does not automatically mean someone is compatible.
3. Searching for an Unrelated Donor
If no suitable family match is found, the transplant team may look for an unrelated donor through an available donor registry or consider other sources of stem cells.
A potential bone marrow donor must have suitable compatibility and meet the transplant team’s medical and safety requirements. The availability of unrelated donors varies, and finding a suitable match may take time.
4. Confirming the Match
Once a potential donor is identified, additional testing may be required to confirm the HLA results and assess the donor’s health. The team also evaluates the recipient’s condition and whether the proposed transplant is appropriate.
This final assessment helps the medical team select the safest and most suitable option for the patient.
What Is an HLA Typing Test, and Why Is It Important?
An HLA typing test identifies the tissue markers used in donor compatibility assessment. It is different from routine blood grouping, which determines whether a person has blood type A, B, AB or O and whether their blood is Rh-positive or Rh-negative.
In transplantation, matching the HLA markers is generally more important than having the same blood group. A donor and recipient may have different blood types and still be considered for transplantation, depending on the clinical circumstances and the transplant team’s protocol.
HLA testing is important because it helps doctors:
- Identify suitable family donors.
- Compare potential unrelated donors.
- Assess the risk of immune-related complications.
- Plan the appropriate transplant approach.
- Determine whether further testing is required.
The test itself generally involves collecting a sample, but interpreting the results and choosing a donor requires specialist medical assessment.
Types of Bone Marrow Donors
Not every patient requires cells from another person. The appropriate donor source depends on the diagnosis, treatment plan and availability of compatible cells.
1. Related Donors
Related donors are family members, such as siblings or parents. A fully matched sibling may be an appropriate option, while a parent, child or other family member may be considered for a partial-match transplant.
2. Unrelated Donors
Unrelated donors are individuals who are not members of the patient’s family but have suitable tissue compatibility. Doctors may search available registries when no appropriate related donor is identified.
3. Haploidentical Donors
A haploidentical donor is a partially matched family member who shares approximately half of the patient’s HLA markers. This approach can expand donor options for patients who do not have a fully matched donor.
4. Umbilical Cord Blood
Blood collected from the umbilical cord and placenta after birth contains blood-forming stem cells. Stored cord blood may be considered for selected patients, and its matching requirements differ from those used for adult donors.
What Happens After a Suitable Donor Is Found?
Finding a match is an important milestone, but transplantation requires further preparation.
The donor undergoes a medical evaluation to ensure that donation can be carried out safely. The patient also receives a detailed assessment, which may include blood tests, infection screening, organ-function tests and other investigations based on their condition.
The team then plans the bone marrow transplant procedure, including the conditioning treatment needed before the transplant.
Depending on the type of transplant, stem cells may be collected from the bloodstream, bone marrow or umbilical cord blood. The cells are then administered to the patient according to the treatment plan.
After transplantation, the patient requires close monitoring. Doctors assess whether the cells have been engrafted, monitor blood counts, and watch for infections, GVHD and other complications. Recovery and follow-up can continue for months or longer.
What Factors Affect Donor Compatibility?
HLA compatibility is central to donor selection, but it is not the only consideration. The transplant team also reviews factors that may affect the safety and outcome of treatment.
Important considerations include:
- HLA compatibility: The degree of matching between the donor and recipient.
- Donor health: Whether the individual can safely donate stem cells.
- Donor availability: Whether the donor can proceed within the required timeframe.
- Patient’s diagnosis: The disease being treated and its current status.
- Age and other clinical factors: These may influence donor selection and expected outcomes.
A fully matched donor is not always the only possible option. Advances in transplantation mean that selected patients may be eligible for a partial-match transplant, depending on their medical needs and the centre’s expertise.
What If a Suitable Donor Cannot Be Found?
Not finding a fully matched donor in the immediate family does not necessarily mean transplantation is impossible.
The transplant team may explore unrelated donor registries, partially matched family members or cord blood. The suitability of each option depends on the patient’s condition, the urgency of treatment and the availability of appropriate stem cells.
Patients should discuss their options with a transplant specialist rather than assuming that a lack of a full family match rules out treatment. Starting the donor search early may also provide more time to identify suitable alternatives.
How Long Does Donor Matching Take?
The timeline varies from patient to patient. It depends on how quickly HLA testing is completed, whether family members are suitable matches, the availability of unrelated donors and the need for additional medical assessments.
Some patients may find a potential donor relatively quickly, while others require a longer search. The transplant team can begin assessing donor options while other aspects of treatment are being arranged.
Early referral to a transplant centre is therefore important when a bone marrow transplant may be needed. It allows the team to evaluate eligibility and begin the search without unnecessary delays.
Final Thoughts
Donor matching is a crucial part of transplantation because it helps doctors identify compatible stem cells and reduce the risk of serious complications. HLA testing, family assessments and searches for unrelated donors all contribute to selecting an appropriate option. Although finding a match can take time, advances in transplantation have expanded the choices available to many patients.
In Pakistan, the National Institute of Blood Disease & Bone Marrow Transplantation (NIBD) provides specialised transplant services for eligible adults and children with conditions including leukaemia, thalassaemia and other blood disorders. Patients can consult its Bone Marrow Transplantation service to learn more about available treatment options and specialist care.
FAQs
1. How is a bone marrow transplant donor selected?
A donor is selected by comparing HLA markers and assessing medical suitability, donor availability and the patient’s clinical needs. Family members are often tested first, followed by a search for other options when necessary.
2. Can a parent be a donor for their child?
Yes. A parent usually shares approximately half of their child’s HLA markers and may be considered for a haploidentical transplant if the transplant team determines it is appropriate.
3. Is blood group matching necessary for a transplant?
Blood group compatibility is not the same as HLA matching. Some transplants can proceed despite differences in blood groups, but the medical team must evaluate the risks and plan accordingly.
4. What is the difference between a bone marrow transplant and a stem cell transplant?
A stem cell transplant uses blood-forming stem cells to restore the body’s ability to produce healthy blood cells. These cells may come from bone marrow, the bloodstream or umbilical cord blood. The term bone marrow transplant is commonly used for this broader treatment.
5. Can a person donate more than once?
Some individuals may be able to donate more than once, depending on the type of donation, their recovery and medical eligibility. A transplant centre must assess the donor’s health and determine whether another donation is safe.
6. What happens if no fully matched donor is available?
The transplant team may consider a partially matched family member, an unrelated donor or cord blood, depending on the patient’s circumstances. The most appropriate option should be decided by an experienced transplant specialist.
